Litcius/Paper detail

Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation

Zaina T. Al-Salama

2021Drugs25 citationsDOI

Topics & Concepts

CetuximabMedicineTolerabilityOncologyColorectal cancerInternal medicineTargeted therapyRegimenClinical trialCancerAdverse effectColorectal Cancer Treatments and StudiesMelanoma and MAPK PathwaysHepatocellular Carcinoma Treatment and Prognosis
Encorafenib: A Review in Metastatic Colorectal Cancer with a BRAF V600E Mutation | Litcius